ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

STX Shield Therapeutics Plc

1.525
0.05 (3.39%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 3.39% 1.525 1.50 1.55 1.525 1.425 1.48 4,566,400 16:18:36
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.29 11.79M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.48p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £11.79 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.29.

Shield Therapeutics Share Discussion Threads

Showing 5151 to 5173 of 23275 messages
Chat Pages: Latest  211  210  209  208  207  206  205  204  203  202  201  200  Older
DateSubjectAuthorDiscuss
15/2/2020
23:19
Nobby,

Fancy a bet here or in metro ?

Metro my bet is > 200p on 26th
Here
IMM > 30p by December 2020

Fancy a bet ?

For IMM I am happy to give you higher odds

Please let me know and we can facilitate bet

marie1980
15/2/2020
23:11
Thank you bes.

Meanwhile here for Nobby from IMM board.


You are a failure and an idiot. You called this wrong before. Thankfully I didn't listen and was in for a decent rise. Definitely won't be listening to you again.

It's a shame you're so bitter and twisted about being proved wrong and missing out you have to stick around like a bad smell polluting this BB.

marie1980
15/2/2020
20:02
Marie1980 I’m invested have been for some time and am also in DNL if they get EMA approval for chronocourt which looks likely FDA is less sure and at least 12/18 months away.
While the long term potential of accrefur Feracru is greater I would expect DNl to grow at a faster rate over the next 2 years and from current valuation DNLwhile carriers greater risk in the short term is extremely attractively valued.
Time will tell as always and while I’m not a fan of ramping or deramping for that matter Just thought I would voice my opinion on DNL

best1467
13/2/2020
20:25
Ny boy on DNL board few days back wrote this


Looks ready to start a momentum move, could do with some decent news to get to 89p though, maybe a target price for Q4

Then couple of days back

Nice update, gap to 35p coming up, as first test

Ny Boy, you are just tarnishing you’re reputation by unnecessary ramping. Atlesst be sensible with your ramping.

And you kept saying DYOR. Love, why can’t you just add “useful” and “researched221; note at the end of your own ramping like this DNL share company will run out of cash by Q3 and hence even after such a solid RNS, share price hardly buzz.

And don’t compare DNL with Shield. Shield product will generate far more millions than DNL.

So stop ramping and be sensible with your post it you want some other member to notice you.

marie1980
13/2/2020
16:27
ny_boy - wrong board again! Please stop pumping and ramping - go on ... try for day at least?

(btw - if you keep finishing your posts with 'do your own research' then there is no need for you to post is there... unless you are pumping.. ;-)

growthinvestor2001
13/2/2020
10:04
Anyone following (DNL), they just got a date from FDA for decision on drug application a bit like where Shield were in March of last year...around 40/50p. I am looking for a x3 + if they get FDA approval at end of Sept...dyor as usual.
ny boy
12/2/2020
17:43
FWIW Medicaid in Virginia has listed Accrufer after a 12 week trial of an oral iron. I believe this is a normal timeline for Medicaid listing. hxxps://www.virginiapremier.com/wp-content/uploads/VPHP_PA_Criteria.pdf
crankyman
12/2/2020
14:13
Usual drivel from ny_boy:

1. Telling us where hes on holiday (who cares or who can prove it?)
2. Generic post related to the board which he has posted countless times before re US deal.
General pump / ramp of other stocks he holds.

Very boring isn't it - please stop ramping/pumping ny_boy - bet you can't.

growthinvestor2001
12/2/2020
14:03
Lol, I hold both, happy to hold, no reason to sell as I bought very cheap, still on Asia relaxing, every day blue sky and warmth, I don’t miss Blighty during the long short and gloomy winter days.

Made a load on NMC, keep a core for potential bid/s

Holding FIN,PPS, ITX and a load of others, which are starting to do well.

Happy days, just awaiting US commercialisation deal here.

Dyor as usual.

ny boy
12/2/2020
12:05
Nobby - IMM flying. up 22% since i quit Shield.
marie1980
11/2/2020
16:26
All comes down to how much you can afford lose...sadly my pockets arnt that deep
kop202
10/2/2020
12:37
I like to form an opinion slightly earlier to catch the large gains not always but you can get it wrong several times and still be making large returns as Long as you get right occasionally and stay in
best1467
09/2/2020
17:57
My experience of AIM is that it is best to hold back and wait till the chances of failure have diminished.The MM's have a habit of causing an overhang in the share price at this time (when the development is at an end and revenue streams are imminient) giving the investor who has done his/ her research plenty of time to enter the market.People always have a FOMO with AIM companys in the development stageMy experience is that is not the case...
kop202
08/2/2020
22:28
While IMM is very high risk Marie could well get a better percentage gain over the next two years but he could also lose All £67k which will not happen here.
I commented over on the IMM board a month or so that if the FDA agree a P3 pathway then from current levels prior to read out a decent return could be made.But I don’t see much action in the next 12 months and not sure what is investment strategy is but it seems a little all in approach but good luck

best1467
08/2/2020
21:17
>> Marie

I say it as it is! I am positive on many stocks, particularly TLY and OPTI. However, Lupuzor will not work if used at the same dose as before. Simples! Yes I know that doesn't matter to you but IMM management are poor so be very careful.

nobbygnome
08/2/2020
20:19
Sorry did I miss your summary nobby? Could you re post ? Thanks
2theduke
08/2/2020
11:06
I like you Nobby.

You’re expert of deramping.

Anyway, to answer your question. Atleast I take a solace that I’m not investing in a binary outcome.

I’m investing in IMM because

1. This is dirt cheap
2. Avion’s track record of turn around the things and considering they put £25m shoes their confidence.
3. Speculation and anticipation nearer to P3 itself will push to around 40-50p level if not 180p like last time.
4. I’m confident FDA will approve P3 with different dosage criteria compared to last time.


One last thing, I’m ready to lose my entire pot of £67K. That’s fine with me. I’m young and I will earn down the line.

But I appreciate your concern. We want get many sympathetic board members like you so much appreciated.

I know once P3 trial approved by FDA with certain protocol, then you will deramp again with “abs signal” in USA patient. Then you will deramp again that last time IMM failed so no way they will succeed again. But honestly, I like you. I wish everyone be as sympathetic and as genuine like you.

All the best.

Sorry stx members. Consider this my last last message and Nobby now feel free to pop over IMM board rather than spam this shield board with other shares.

Cheers and have a lovely weekend.

marie1980
08/2/2020
08:30
Wow £65k in IMM. I am not sure you realise the risk you are taking. What will the price be if Avion pull out because of issues with the FDA? From my knowledge of the drug and how the FDA works, that is a perfectly possible scenario. There are no guarantees they will agree to the phase III trial plan. Remember that the anti-DNA ab 'signal' was not present in US patients. IMM can't have it both ways. If that data is significant in Europe, then you have to say it is not significant in the US.

I am not saying it will happen but it is possible.

nobbygnome
07/2/2020
15:36
Agree KoP... and consider this is my last message in Sheild.

I've had good fun and return in STX.

Adios!!

Take care and I'm pretty sure this will easily go past to £2.5 once US deal announced.

marie1980
07/2/2020
14:35
Poor use of capital imo...IMM is going nowhere fast..
kop202
07/2/2020
14:13
I don't know Kop202,

But with that I've now sold all my £16,000
and invested fully in IMM.

My total investment in IMM is now £65,000

Happy to wait for 2-4 years.

marie1980
07/2/2020
14:08
Marie...your a bit of an optomist to say the least......whats changed since the share price collapse in IMM?
kop202
07/2/2020
13:49
110% agree with you Nobby but the profit I know I'll get in IMM over next 2 years will be far more than here in Shield.

But yes, your point is perfectly valid. It's just I see move value there rather than here.

marie1980
Chat Pages: Latest  211  210  209  208  207  206  205  204  203  202  201  200  Older

Your Recent History

Delayed Upgrade Clock